Mereo BioPharma Group plc
MREO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43 | -$29 | -$42 | $19 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $5 | $5 | $4 |
| Change in WC | -$0 | -$2 | -$2 | -$2 |
| Other Non-Cash | $2 | $4 | -$10 | -$29 |
| Operating Cash Flow | -$33 | -$21 | -$49 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | $2 | $0 |
| Investing Cash Flow | -$1 | -$0 | $2 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3 | $0 | -$1 |
| Stock Issued | $47 | $12 | $0 | $106 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$0 | $0 | -$0 |
| Financing Cash Flow | $46 | $8 | $0 | $105 |
| Forex Effect | -$0 | $3 | -$13 | -$2 |
| Net Chg. in Cash | $12 | -$11 | -$59 | $96 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57 | $68 | $127 | $32 |
| End Cash | $70 | $57 | $68 | $127 |
| Free Cash Flow | -$34 | -$22 | -$49 | -$8 |